The intestinal microbiota and host immune interactions in the critically ill - PubMed (original) (raw)
Review
The intestinal microbiota and host immune interactions in the critically ill
Tim J Schuijt et al. Trends Microbiol. 2013 May.
Abstract
The gastrointestinal tract harbors a complex population of microbes that play a fundamental role in the development of the immune system and human health. Besides an important local contribution in the host defense against infections, it has become increasingly clear that intestinal bacteria also modulate immune responses at systemic sites. These new insights can be of profound clinical relevance especially for intensive care medicine where the majority of patients are treated with antibiotics, which have pervasive and long-term effects on the intestinal microbiota. Moreover, considerable progress has been made in defining the role of the intestinal microbiota in both health and disease. In this review, we highlight these aspects and focus on recent key findings addressing the role of intestinal microbiota in antimicrobial defense mechanisms and its impact on intestinal homeostasis in the critically ill.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
- Nod-like receptors in intestinal host defense: controlling pathogens, the microbiota, or both?
Robertson SJ, Girardin SE. Robertson SJ, et al. Curr Opin Gastroenterol. 2013 Jan;29(1):15-22. doi: 10.1097/MOG.0b013e32835a68ea. Curr Opin Gastroenterol. 2013. PMID: 23132210 Review. - Effects of interactions between intestinal microbiota and intestinal macrophages on health.
Nakata K, Yamamoto M, Inagawa H, Soma G. Nakata K, et al. Anticancer Res. 2013 Jul;33(7):2849-53. Anticancer Res. 2013. PMID: 23780969 Review. - The contributing role of the intestinal microbiota in stressor-induced increases in susceptibility to enteric infection and systemic immunomodulation.
Bailey MT. Bailey MT. Horm Behav. 2012 Aug;62(3):286-94. doi: 10.1016/j.yhbeh.2012.02.006. Epub 2012 Feb 15. Horm Behav. 2012. PMID: 22366706 Review. - New insights into the impact of the intestinal microbiota on health and disease: a symposium report.
Thomas LV, Ockhuizen T. Thomas LV, et al. Br J Nutr. 2012 Jan;107 Suppl 1:S1-13. doi: 10.1017/S0007114511006970. Br J Nutr. 2012. PMID: 22260731 - Impact of the intestinal microbiota on the development of mucosal defense.
Gaskins HR, Croix JA, Nakamura N, Nava GM. Gaskins HR, et al. Clin Infect Dis. 2008 Feb 1;46 Suppl 2:S80-6; discussion S144-51. doi: 10.1086/523336. Clin Infect Dis. 2008. PMID: 18181729 Review.
Cited by
- Acute Gastrointestinal Injury in Polytrauma: Special Attention to Elderly Patients.
Zhang C, Chang T, Chen D, Luo J, Chen S, Zhang P, Lin Z, Luo J, Zhou Q, Wang W, Xu H, Dong L, Tang Z. Zhang C, et al. Int J Med Sci. 2024 Aug 26;21(12):2315-2323. doi: 10.7150/ijms.98997. eCollection 2024. Int J Med Sci. 2024. PMID: 39310259 Free PMC article. - Gut commensal metabolite rhamnose promotes macrophages phagocytosis by activating SLC12A4 and protects against sepsis in mice.
Li D, Wei R, Zhang X, Gong S, Wan M, Wang F, Li J, Chen M, Liu R, Wan Y, Hong Y, Zeng Z, Gu P, Wang Z, Selva Nandakumar K, Jiang Y, Zhou H, Chen P. Li D, et al. Acta Pharm Sin B. 2024 Jul;14(7):3068-3085. doi: 10.1016/j.apsb.2024.03.025. Epub 2024 Mar 22. Acta Pharm Sin B. 2024. PMID: 39027244 Free PMC article. - A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease.
Aktas B, Aslim B, Ozdemir DA. Aktas B, et al. Sci Rep. 2024 Jul 4;14(1):15460. doi: 10.1038/s41598-024-65061-w. Sci Rep. 2024. PMID: 38965287 Free PMC article. - The causality of gut microbiota on onset and progression of sepsis: a bi-directional Mendelian randomization analysis.
Gao Y, Liu L, Cui Y, Zhang J, Wu X. Gao Y, et al. Front Immunol. 2024 Apr 18;15:1266579. doi: 10.3389/fimmu.2024.1266579. eCollection 2024. Front Immunol. 2024. PMID: 38698853 Free PMC article. - Causal relationship between gut Prevotellaceae and risk of sepsis: a two-sample Mendelian randomization and clinical retrospective study in the framework of predictive, preventive, and personalized medicine.
Luo Y, Zhou Y, Huang P, Zhang Q, Luan F, Peng Y, Wei J, Li N, Wang C, Wang X, Zhang J, Yu K, Zhao M, Wang C. Luo Y, et al. EPMA J. 2023 Oct 12;14(4):697-711. doi: 10.1007/s13167-023-00340-6. eCollection 2023 Dec. EPMA J. 2023. PMID: 38094582
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources